|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.555 USD | -2.85% |
|
+10.09% | +57.36% |
| Market Cap | 491M 425M 397M 363M 684M 46.82B 695M 4.66B 1.83B 23.42B 1.84B 1.8B 78B | P/E 2026 * |
-5.45x | P/E 2027 * | -5.01x |
|---|---|---|---|---|---|
| Enterprise Value | 491M 425M 397M 363M 684M 46.82B 695M 4.66B 1.83B 23.42B 1.84B 1.8B 78B | EV / Sales 2026 * |
4,566x | EV / Sales 2027 * | 2,945x |
| Free-Float |
92.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | -2.47% | ||
| 1 week | +10.09% | ||
| Current month | +15.54% | ||
| 1 month | +1.79% | ||
| 3 months | -8.06% | ||
| 6 months | +56.40% | ||
| Current year | +57.36% |
| 1 week | 2.33 | 2.69 | |
| 1 month | 2.2 | 2.69 | |
| Current year | 1.36 | 3.1 | |
| 1 year | 0.52 | 3.1 | |
| 3 years | 0.24 | 4.14 | |
| 5 years | 0.24 | 4.2 | |
| 10 years | 0.24 | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 31/12/2025 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 05/07/2026 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 31/03/2014 |
Bart Friedman
BRD | Director/Board Member | 81 | 22/11/2015 |
Barbara Duncan
BRD | Director/Board Member | 61 | 13/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 06/07/26 | Other | Chief Financial Officer | 450,625 | 0.2414% | ||
| 07/04/26 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.85% | +10.09% | +361.58% | -27.13% | 491M | ||
| +4.21% | +25.62% | +77.96% | +111.62% | 68.12B | ||
| +0.50% | +6.20% | +38.65% | +67.83% | 55.18B | ||
| +1.42% | +35.25% | +17.95% | +486.05% | 28.63B | ||
| +0.57% | +19.05% | +57.08% | +5.18% | 23.99B | ||
| -0.67% | +1.08% | -14.65% | -11.58% | 23.53B | ||
| -0.35% | +7.91% | +46.74% | -22.61% | 18.45B | ||
| -2.04% | +9.24% | +31.14% | +650.71% | 16.44B | ||
| +7.26% | +25.47% | +221.03% | +383.67% | 15.83B | ||
| -2.09% | -4.40% | +40.70% | +148.87% | 13.4B | ||
| Average | +0.64% | +12.03% | +87.82% | +179.26% | 26.41B | |
| Weighted average by Cap. | +1.54% | +11.65% | +55.21% | +164.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108K 93.06K 86.99K 79.5K 150K 10.25M 152K 1.02M 400K 5.13M 404K 395K 17.08M | 167K 144K 135K 123K 232K 15.9M 236K 1.58M 621K 7.95M 626K 612K 26.49M |
| Net income | -77.12M -66.76M -62.4M -57.03M -107M -7.36B -109M -732M -287M -3.68B -290M -283M -12.26B | -89.58M -77.55M -72.48M -66.25M -125M -8.54B -127M -850M -334M -4.27B -336M -329M -14.24B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | US$2.540 | -3.42% | 457,386 |
| 07/08/26 | US$2.630 | -0.75% | 919,698 |
| 06/08/26 | US$2.650 | +1.15% | 1,294,431 |
| 05/08/26 | US$2.620 | +3.15% | 2,253,578 |
| 04/08/26 | US$2.540 | +9.01% | 1,666,461 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions

















